Eliem Therapeutics Inc (ELYM) Financials

$3.09

$-0.14 (-4.33%)

As on 04-Dec-2024 09:30EDT

Market cap

$343 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	17.84	37.41	45.14	35.67	11.77	4.70
Operating Profit (EBIT)	-17.84	-21.47	-45.14	-35.67	-20.93	-7.45
Other Income	--	--	-0.11	-11.81	--	--
Profit before Tax	-64.20	-35.12	-45.24	-47.48	-20.67	-6.55
Provision for Tax	-3.01	-0.02	0.11	-0.07	-9.16	-2.75
Profit after Tax (Net Income)	-64.20	-35.12	-45.35	-47.48	-11.51	-3.80
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-45.24	-52.03	-22.95	-7.39

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	222.28	107.60	128.72	167.20	21.57	20.61
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.04	0.18	0.01	1.09	0.65
Current Liabilities	3.74	2.83	6.10	6.03	3.06	0.78
Total Liabilities	229.76	110.47	134.99	173.24	24.63	21.40

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.02	0.21	0.60	24.99	2.63	0.11
Current Assets	226.00	110.26	134.39	148.25	22.00	21.28
Total Assets	229.76	110.47	134.99	173.24	24.63	21.40
Total Debt*	0.10	0.35	0.48	--	--	--
Net Current Assets	222.26	107.42	128.30	142.22	18.94	20.50

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-20.60	-37.37	-36.07	-14.10	-5.01
Cash Flow from Investing Activities	--	--	34.44	-114.97	8.08	8.08
Cash from Financing Activities	--	0.84	0.04	177.23	4.93	26.24
Net Cash Inflow / Outflow	--	--	-2.93	26.19	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-29.62	-30.60	-50.30	-54.58	--
ROE (%)	-38.92	-29.72	-30.65	-50.30	-54.58	--
ROA (%)	-36.72	-28.61	-29.43	-47.99	-50.02	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	41,608.26	402.10	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	57.20	60.45	-24.74	-386.39	-96.52	--
Net Profit Growth (%)	-49.47	22.57	4.48	-312.51	-203.13	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.97	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.58	7.80	2.82	3.84	--	--
Close Price ($)	7.11	2.70	3.67	10.46	--	--
High Price ($)	11.55	4.75	13.74	29.69	--	--
Low Price ($)	2.35	2.21	2.36	8.16	--	--
Market Cap ($ Cr)	342.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.00	0.00	--	--	--
Short term debt to equity ratio	0.00	0.01	0.00	--	--	--
Current Ratio	60.41	38.92	22.04	24.58	7.18	27.18
Quick Ratio	60.41	--	23.11	23.85	--	--
Interest Coverage	-26.96	--	-55.74	-6.13	--	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.